COMMUNIQUÉS West-GlobeNewswire

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results
12/03/2024
Release Includes Commentary on Early 2024 Progress SOLANA BEACH, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company [...]
MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
12/03/2024
ROCKVILLE, Md., March 12, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development, [...]
Clover Health Reports Fourth Quarter and Full Year 2023 Financial Results; Delivers Continued Momentum in Financial Performance and Provides Full-Year 2024 Guidance
12/03/2024
Full-year 2023 Insurance MCR improved to 81.2% and fourth quarter MCR to 82.4% Company improves full-year 2023 Net Loss by $126.2 million and full-year Adjusted EBITDA by $245.7 million year-over-year Issues 2024 [...]
Apogee Therapeutics, Inc. Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $483 Million
12/03/2024
SAN FRANCISCO, Calif. and WALTHAM, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company seeking to develop differentiated biologics for the treatment [...]
Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days
12/03/2024
VANCOUVER, British Columbia, March 12, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the Stifel 2024 [...]
iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results
12/03/2024
Annual Recurring Revenue of $8.7 million, an increase of 15% year-over-year Full-Year Operating Cash Flow ($5) million vs. ($12.8) million prior year Year ending cash balance of $21.7M NASHUA, N.H., March 12, 2024 ( [...]
Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering
12/03/2024
Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering IRVINE, CA, and HERSTAL, BELGIUM – March 12, 2024 ( GlobeNewswire ) – MDxHealth SA (NASDAQ: MDXH) (the “Company” or “mdxhealth”), a [...]
Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days
12/03/2024
CHARLOTTESVILLE, Va., March 12, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta [...]
Neurona Therapeutics to Present at Stifel 2024 Virtual CNS Days
12/03/2024
SAN FRANCISCO, March 12, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics , a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, today [...]
ASLAN Pharmaceuticals Announces $5 Million Registered Direct Offering
12/03/2024
SAN MATEO, Calif. and SINGAPORE, March 12, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals Ltd. (Nasdaq: ASLN), a clinical-stage, immunology focused biopharmaceutical company developing innovative treatments to transform [...]
Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
12/03/2024
TORONTO and EDMONTON, Alberta, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“ Aeterna ”) and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“ Ceapro ”) are pleased to announce that [...]
Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
12/03/2024
TORONTO and EDMONTON, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“ Aeterna ”) and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“ Ceapro ”) are pleased to announce that [...]
UPDATE -- Fractyl Health Announces New Results From Its Rejuva® Platform Demonstrating Potent and Durable Effects of a Single Dose of a Human GLP-1 Pancreatic Gene Therapy Transgene Compared to Semaglutide in the db/db Mouse Model of Diabetes and Obesity
12/03/2024
Data provides first demonstration of glucose lowering and weight loss potency from pancreas-produced native human GLP-1, highlighting the capacity of pancreatic GLP-1 to provide metabolic control. The human GLP-1 [...]
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
12/03/2024
COPENHAGEN, Denmark, March 12, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related securities by persons holding managerial [...]
ARC Resources Ltd. donates $5 million to OWN.CANCER Campaign ahead of opening of new Arthur J.E. Child Comprehensive Cancer Centre in Calgary
12/03/2024
This is the campaign’s largest corporate gift and will support clinical trials and innovations in radiation oncology CALGARY, Alberta, March 12, 2024 (GLOBE NEWSWIRE) -- The Alberta Cancer Foundation, along with Alberta [...]
Fortrea signe un accord définitif pour céder les activités Endpoint Clinical et Patient Access à Arsenal Capital Partners
12/03/2024
Le projet de cession des activités Endpoint Clinical et Fortrea Patient Access permet à Fortrea de se recentrer sur son cœur de métier stratégique d’organisme de recherche contractuelle Création de solutions autonomes [...]
SaharaBets Partners with Birches Health to Increase Accessibility to Responsible Gaming Resources and Problem Gambling Treatment
12/03/2024
PHOENIX, Arizona, March 12, 2024 (GLOBE NEWSWIRE) -- SaharaBets and Birches Health announced the formation of a partnership focusing on proactive engagement and education in Responsible Gaming. The partnership provides [...]
Ibogaine By David Dardashti Announces New Algorithm to Address PTSD
12/03/2024
Groundbreaking Algorithm to Help Treat Trauma Victims MIAMI, March 12, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti , a company that specializes in helping people heal from trauma, has announced a revolutionary [...]
Astrocyte Pharmaceuticals Announces FDA Clearance of its Investigational New Drug Application for AST-004
12/03/2024
Green Light for Phase 2 Trial of AST-004 in Acute Ischemic Stroke Patients GROTON, Conn., March 12, 2024 (GLOBE NEWSWIRE) -- Astrocyte Pharmaceuticals Inc. , a clinical-stage biopharmaceutical company committed to [...]

Pages